// App-Quantinova.ai

M4469 2015 AHA : Predictors of Hospitalization and Effects of Dabigatran and Warfarin on Hospitalization Rates: An Analysis From The Re-ly Trial

Researchers

Presenter

  • Aiman Alak

Principal Investigators

  • Stuart J Connolly

  • Mandy Fraessdorf

  • Martina Brueckmann

  • Michael D Ezekowitz

  • Paul Reilly

  • Salim Yusuf

  • Lars Wallentin

Medical Centers

  • Uppsala Clinical Research Center, Uppsala, Sweden

  • McMaster University, Hamilton, ON, Canada

  • Jefferson Medical College, Philadelphia, PA

Locations

  • United States

  • Canada

  • Sweden

Companies

  • Boehringer Ingelheim

Study Components

Therapeutic Area

  • Endocrine/metabolic Diseases (ME)

Disease

  • Peripheral artery disease

  • Coronary Artery Disease

  • Arrhythmia

  • Renal insufficiency

  • Congestive heart failure

  • Hypertension

  • Diabetes

Biomarkers

  • N/A

Drug/Treatment

  • Pradax

  • Warfarin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved